The differences of clinical effect on bone density between Non-Vitamin K Oral Antagonist (NOAC) and Vitamin K Antagonist (VKA)

ISTH Academy, Kengo Ayabe, 264342

The Effect Of Fasting Ramadan On the Efficacy And Safety Of Oral Anticoagulants

ISTH Academy, Fakhr Alayoubi, 264343

Assessing the impact of switching to the tobacco heating system on cardiovascular events: translating basic science into clinical benefit

ISTH Academy, Calin Pater, 264344

Experiences In Carotid Artery Dissection In Children

ISTH Academy, Patcharee Komvilaisak, 264365

Audit of the use of the GEKO device on an Acute Stroke Unit (ASU)

ISTH Academy, Sue Rhodes, 264366

Immunohistologic analysis of von Willebrand factor in thrombi retrieved from patients with acute ischemic stroke

ISTH Academy, Hisao Shimizu, 264367

Thrombin-mediated activation of factor VIII is insufficient to produce all necessary cofactor activity in vivo

ISTH Academy, Ivan Peyron, 264382

The traceability of commercial plasma calibrators to the plasma international standard for factor IX

ISTH Academy, Helen Wilmot, 264383

Heterogeneity in levels of FVIII and VWF expression in subpopulations of human endothelial cells

ISTH Academy, David Lillicrap, 264384

Evaluation of endothelial dysfunction and hypercoagulability markers in sickle cell anemia patients with and without hydroxyurea therapy

ISTH Academy, Bidossessi Wilfried Hounkpe, 264399

Coagulation imbalance in patients with Acute-on-Chronic Liver Failure (ACLF) measured by global and classical coagulation tests

ISTH Academy, Elena Campello, 264400

ADAMTS-13 and Von Willebrand Factor involved in Portal Vein Thrombosis development in cirrhotic patients

ISTH Academy, Monica Sacco, 264401

New, highly sensitive and specific multiplatform latex automated turbidimetric assay for measurement of Free Protein S in plasma

ISTH Academy, Claire Dunois, 264417

polymorphisms in non-coding regions of the protein c gene regulate plasmatic protein c levels

ISTH Academy, Julia Oto, 264418

Competitive binding, and accounting for procoagulant platelets, significantly change thrombin profiles in in vitro coagulation

ISTH Academy, Mohan Anand, 264419

Investigation of Pharmacodynamic Biomarkers and Neutralizers for ONO-7684 (ONO-5450598), an Oral FXIa Inhibitor

ISTH Academy, Sho Kouyama, 264437

Abstract 1: Assessment of Validated Risk Assessment Models and a Biomarker Ubiquitous in Routine Clinical Care to Identify Hospitalized Medical Patients at Risk for 90-day Post-discharge Venous Thromboembolism

ISTH Academy, Scott Woller, 264438

Laboratory marker of hypercoagulability: a ratio combining thrombin-generation with fibrin-clot-formation

ISTH Academy, Debora Bertaggia-Calderara, 264439

Abstract 2: Comparative Benefit of Adding a Biomarker Ubiquitously Available in Clinical Care to Validated Risk Assessment Models for the Identification of Hospitalized Medical Patients at Risk for 90-day Hospital-associated Venous Thromboembolism

ISTH Academy, Scott Stevens, 264456

Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: a cost-effectiveness analysis

ISTH Academy, Marc Blondon, 264457

Relationship of type 1 Plasminogen Activator Inhibitor with Glycosilated Hemoglobin levels in type 2 Diabetic Patients - Guillermo Almenara National Hospital - ESSALUD - Lima, 2016

ISTH Academy, Haydee Iparraguirre Lopez, 264458

Evaluation of thrombin generation in patients with dermatomyositis and polymyositis

ISTH Academy, Jerzy Dropinski, 264472

Factors Associated with a Negative D-dimer Test in Patients Diagnosed with Acute Symptomatic Pulmonary Embolism

ISTH Academy, Stefano Barco, 264474

The FDP/D-dimer ratio and LDH/Hb ratio are useful to distinguish between TTP and DIC

ISTH Academy, Nobushiro Nishimura, 264475

Performance evaluation of a new fully automated thrombin generation instrument for the measurement of TGA in Haemophilia samples

ISTH Academy, Nikolaus Bernhard Binder, 264489

Use of chromogenic Factor VIII activity determination in Haemophilia A plasma of patients under emicizumab treatment

ISTH Academy, Nikolaus Bernhard Binder, 264490

Development of a point-of-care diagnostic test to identify and differentiate between factor-deficient and autoantibody-induced hemophilia A, B and C

ISTH Academy, Galit Frydman, 264491

Correlation of bleeding scores with Flowcytometry Platelet Aggregation test in patients with a suspected bleeding disorder

ISTH Academy, Jasmina Ahluwalia, 264507

Exome sequence findings and bleeding manifestations for uncharacterized platelet function disorders with impaired aggregation responses and/or non-syndromic dense granule deficiency: Results from the Hamilton Platelet Disorder Study

ISTH Academy, Catherine Hayward, 264508

Microscopic Platelet Adhesion Assessment - An Approach towards Standardization

ISTH Academy, Johanna Charlotte Clauser, 264509

Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis

ISTH Academy, Joachim C Mertens, 264527

Features of the action of a new synthetic peptide of the melanocortin family on fibrinolysis

ISTH Academy, Tatyana Shubina, 264528

Towards the structure-function analysis of factor VII activating protease (FSAP)

ISTH Academy, Dipankar Manna, 264529

Determinants of plasma fibrin clot lysis using three different assays in patients with aortic stenosis

ISTH Academy, Jakub Siudut, 264544

Elucidation of the molecular mechanisms of nanobodies that affect plasminogen activator inhibitor 1 (PAI-1) activity highlights their versatility in modulating various stages in the PAI-1/plasminogen activator (PA) interaction

ISTH Academy, Paul Declerck, 264546

Single institution experience of thrombolysis for acute pulmonary embolism in a retrospective cohort of Australian patients

ISTH Academy, Ming Sheng Lim, 264548

Acquired Hemophilia A (AHA) : A Single Centre Malaysian Outlook

ISTH Academy, Christopher, Chin Keong Liam, 264564

Validation of hemostatic impairment induced by hydroxyethyl starch (HES) due to influence on vascular endothelium

ISTH Academy, Ryu Azumaguchi, 264565

New elements involved in the skin haemorrhage induced by snake venom metalloproteinases: proteoglycans and platelet-derived growth factor receptor

ISTH Academy, Solange M T Serrano, 264566

THE EVALUATION OF PAROXISMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WHO UNDERWENT ECULIZUMAB THERAPY

ISTH Academy, Fahri Şahin, 264581

Reported Presentation, Treatment, Mutation Analysis and Outcome of Two Children with Atypical Hemolytic Uremic Syndrome

ISTH Academy, Pongpak Pongphitcha, 264582

Effect of complement activation in septic disseminated intravascular coagulation

ISTH Academy, Tomohiro Abe, 264583

Anti-FVIII IgG1 antibodies in patients with hemophilia A during factor VIII replacement: results from the HEMFIL Study

ISTH Academy, Letícia Lemos Jardim, 264598

Evaluation of the analytical performances of a new emicizumab assay on STA-R & STA Compact Max

ISTH Academy, Matthieu Bourdin, 264599

Long-term outcomes after switch from on-demand treatment to prophylaxis with rFVIIIFc: longitudinal subgroup analysis of the A-LONG and ASPIRE study population

ISTH Academy, Maria Teresa Roman, 264600

Comparison of Pharmacokinetic Outputs from a Non-compartmental Analysis and myPKFiT™ in Taiwanese Hemophilia Patients

ISTH Academy, Shin-Nan Cheng, 264614

Survey of Haemophilia Care in Nigeria: Physicians response from 35 centres in 20 states of the Federation

ISTH Academy, Wuraola A. Shokunbi, 264615

HLA-DR Processing and Presentation of Two Peptide Antigen Clusters in PEG-BDD-FVIII (BAY94-9027) by Dendritic Cells is Impaired Resulting in Defective T-helper Response In Vitro

ISTH Academy, Pedro Paz, 264616

Major impact of the World Federation of Hemophilia humanitarian aid program on initiation of primary prophylaxis with extended half-life Factor VIII and IX in Côte d’Ivoire

ISTH Academy, Cedric Hermans, 264631

Transition from standard half-life to extended half-life products in patients with haemophilia A and B: a single center experience

ISTH Academy, Marissa Traets, 264632

THE EXPERIENCE OF MAJOR ORTHOPEDIC SURGERIES IN PATIENTS WITH SEVERE HEMOPHILIA

ISTH Academy, Alphan Kupesiz, 264633

Results from a Prospective, Multicenter, Dose Escalating, Prophylaxis Study in Young Boys with Severe Haemophilia A in China: The China Haemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)

ISTH Academy, Runhui Wu, 264647

Social Participation of Patients with Haemophilia: Preliminary Results from the Nationwide ‘Haemophilia in the Netherlands 6 study’

ISTH Academy, Erna Van Balen, 264648

Immune Tolerance Induction with Simoctocog Alfa in Nine Patients with Severe Haemophilia A and FVIII Inhibitors

ISTH Academy, Ri J Liesner, 264649

Reversal of anticoagulation in patients on rivaroxaban or apixaban (DOAC) with major bleeding episodes (MBE) with 4 factor prothrombin complex concentrates (PCC): a multicentre retrospective study

ISTH Academy, Christian Gallardo, 264666

Injectable biotinylated platelets for transfusion in clinical trials

ISTH Academy, Arnaud Dupuis, 264668

Thromboelastometry in patients with positive lupus anticoagulant. Is there any potential impact on haemostasis monitoring during Cardiovascular Surgery?

ISTH Academy, Marina Lopez, 264669

Direct Xa-inhibitor reversal with a 4-factor prothrombin complex concentrate prior to urgent surgery

ISTH Academy, Paul P Dobesh, 264683

Comparative Studies on the anticoagulant activities of orally active anti-Xa and anti-IIa agents in whole blood and retrieved plasma and their neutralization by FEIBA

ISTH Academy, Rithik Raina, 264684

Idarucizumab for dabigatran reversal in clinical practice: a French retrospective study of 41 cases

ISTH Academy, Nicolas Gendron, 264685

HIGH PLASMATIC LEVELS OF CELL FREE DNA ARE ASSOCIATED WITH POOR PROGNOSIS IN SEPTIC PATIENTS

ISTH Academy, Mauro Moiana, 264701

Venous Thromboembolism Trends and Impact in Patients with Rheumatoid Arthritis: Analysis of The National Inpatient Sample Database 2003-2014

ISTH Academy, Guillermo Tafur, 264702

Activation-specific small binding proteins targeted towards the integrin Mac-1 - Measuring inflammation by means of monocyte activation in STEMI- and ECMO-patients

ISTH Academy, Patrick Siegel, 264703

The Role of Serotonin on Haematopoiesis and Proplatelet Formation

ISTH Academy, Mo Yang, 264717

Buffy coat, a potential source of hematopoietic stem cells for in vitro platelet production

ISTH Academy, Irene Marini, 264718

Aerobic glycolysis and the consequent flux through pentose phosphate pathway fuel platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents

ISTH Academy, Paresh Kulkarni, 264719

Moderate decreased platelet counts but high platelet activation defects alter hemostasis and arterial thrombosis after partial hepatectomy in mice

ISTH Academy, Lili Donner, 264735

Simultaneous secretion of spatially-separated dense granules in single platelets upon their activation with ADP and thrombin

ISTH Academy, Taisia Shepeliuk, 264736

Continuous flow cytometry assay of platelet signalling and function: a tool for characterization of inherited and acquired platelet disorders

ISTH Academy, Alexey Martyanov, 264737

ABT-737 triggers caspase-dependent inhibition of platelet procoagulant extracellular vesicle release during apoptosis and secondary necrosis in vitro

ISTH Academy, Matthew Harper, 264751

Platelets express a truncated form of TrkB involved in BDNF signaling

ISTH Academy, Imane Boukhatem, 264752

Study on the mechanism of SCUBE1 in regulating platelet function

ISTH Academy, Xianghui Zhou, 264753

Adult onset hereditary thrombotic thrombocytopenic purpura (TTP) with a novel ADAMTS13 mutation

ISTH Academy, Julian Matias Freue, 264770

Cost of Illness (COI) of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) in the United States

ISTH Academy, Abiola Oladapo, 264771

Design of the First Clinical Study of Recombinant ADAMTS13 for the Acute Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

ISTH Academy, Christopher Hibbard, 264772

Severe hemolytic jaundice with thrombocytopenia at birth in congenital TTP is caused by physiological constriction of ductus arteriosus

ISTH Academy, Kazuya Sakai, 264786

Non-severe Congenital Deficiency of ADAMTS13 Presenting as Thrombotic Microangiopathy during Pregnancy

ISTH Academy, Miguel Escobar, 264787

Complement Abnormalities in a Cohort of Argentinean Patients with Atypical Hemolytic Uremic Syndrome

ISTH Academy, Celia Dos Santos, 264788

Potency Adjusted Bovine Heparin is Comparable to Porcine Heparin in Patients Undergoing Open Heart Surgery

ISTH Academy, Ahmed Kouta, 264803

Enoxaparins Derived from Ovine (Sheep) Tissues are Biosimilar to Branded Enoxaparin of Porcine (Pig) Origin

ISTH Academy, Tishya Indran, 264804

Heparins Derived from Ovine (Sheep) Mucosa are Interchangeable to their Porcine (Pig) Counterparts

ISTH Academy, Tishya Indran, 264805

Decreased plasma fibrinolytic potential in venous thrombosis patients using CloFAL assay and the association with post-thrombotic syndrome and residual thrombus

ISTH Academy, Melissa Quintero, 264820

Virchow’s triad: is it applicable to thrombosis of mesenteric vessels?

ISTH Academy, Bushra Moiz, 264821

Utility of the DASH score after unprovoked venous thromboembolism: single centre study and long-term patient outcomes

ISTH Academy, Will Thomas, 264822

Birth of a coagulation clinic and its burden at the department of clinical hematology, Yangon General Hospital, Myanmar

ISTH Academy, SEIN WIN, 264837

Outcomes of NOAC-treated patients with depression - results from the Dresden NOAC Registry (NCT01588119)

ISTH Academy, Jan Beyer-Westendorf, 264838

The role of anxiety and depression in the pathogenesis of thromboembolic events currently classified as unprovoked

ISTH Academy, Silvia Hoirisch-Clapauch, 264839

Risk factors of Recurrences after Stopping Anticoagulant of First Non-Cancer Related Venous Thromboembolism in Thai Patients: A Prospective Cohort Study

ISTH Academy, Pitiphong Kijrattanakul, 264852

Dual antiplatelet therapy on Veno-Arterial ECMO: to bleed or not to bleed?

ISTH Academy, Christophe Vandenbriele, 264854

Non hepatic causes of Adult Splanchnic Vein Thrombosis. A monocentric report of 24 cases

ISTH Academy, Zoubida Tazi Mezalek, 264855

Interim analysis - Safety and efficacy of rivaroxaban in a patient population with short bowel syndrome; a prospective observational cohort study

ISTH Academy, Roisin Bavalia, 264856

Direct oral anticoagulants for the treatment of cerebral venous thrombosis

ISTH Academy, Antoine Lurkin, 264870

Predicting recurrence after unprovoked venous thromboembolism: Comparison of DASH, HERDOO2, and Vienna score in the same cohort of patients

ISTH Academy, Stephany Cares Huber, 264871

Antithrombin and D-dimer in predicting pregnancy complications in the 3rd trimester of pregnancy

ISTH Academy, Ning Tang, 264874

Assessment of the Knowledge about Venous Thromboembolism (VTE) on Pregnant Women Attending Kigali Referral Hospitals

ISTH Academy, Christine Ashimwe, 264877

Is platelets count useful for preeclampsia diagnosis?

ISTH Academy, Luci Dusse, 264893

Systemic Soluble Mediators in HELLP Syndrome Case Report

ISTH Academy, Luci Dusse, 264895

The Challenges of Managing Severe Haemophilia A and Pregnancy in Same Sex Couples

ISTH Academy, Bella Madan, 264896

Pregnancy, childbirth and neonatal outcomes in women with inherited bleeding disorders

ISTH Academy, Lisa Clarke, 264897

Patients with High Post-endovascular Treatment Plasma Levels of Neutrophil Activation Markers Are at Higher Risk of Poor Functional Outcome, HT and Mortality

ISTH Academy, Martine Jandrot-Perrus, 273263